218 related articles for article (PubMed ID: 27666321)
1. Diagnostic work-up of patients presenting in primary care with lower abdominal symptoms: which faecal test and triage strategy should be used?
Fraser CG
BMC Med; 2016 Sep; 14(1):139. PubMed ID: 27666321
[TBL] [Abstract][Full Text] [Related]
2. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
3. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study.
Elias SG; Kok L; de Wit NJ; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG
BMC Med; 2016 Sep; 14(1):141. PubMed ID: 27666114
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
5. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies.
Fraser CG
Gastroenterol Hepatol; 2019 Apr; 42(4):263-270. PubMed ID: 30459060
[TBL] [Abstract][Full Text] [Related]
7. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
Fraser CG
Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
[TBL] [Abstract][Full Text] [Related]
8. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin is not necessarily required as a screen for significant bowel disease in primary care.
Waite MMA; Langmead L; Ayling RM
Ann Clin Biochem; 2022 May; 59(3):171-177. PubMed ID: 34958262
[TBL] [Abstract][Full Text] [Related]
10. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
11. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
12. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
[TBL] [Abstract][Full Text] [Related]
14. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
[TBL] [Abstract][Full Text] [Related]
15. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
16. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies.
Clark GRC; Strachan JA; McPherson A; Digby J; Mowat C; Steele RJC; Fraser CG
Clin Chem Lab Med; 2020 Nov; 58(12):2073-2080. PubMed ID: 32324157
[TBL] [Abstract][Full Text] [Related]
17. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
18. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
Saw KS; Liu C; Xu W; Varghese C; Parry S; Bissett I
Br J Surg; 2022 Feb; 109(2):182-190. PubMed ID: 34907419
[TBL] [Abstract][Full Text] [Related]
19. Impact of faecal haemoglobin based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis.
Delson D; Ward M; Haddock R; Nobes J; Digby J; Strachan JA; Mowat C
Colorectal Dis; 2023 Apr; 25(4):787-793. PubMed ID: 36495081
[TBL] [Abstract][Full Text] [Related]
20. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
